Clinical Trial Update: LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on LAL-AR-N-2005 studying treatment for children with high-risk acute lymphoblastic leukemia. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: COMPLETED